SenesTech, Inc. - Common Stock (SNES)
0.6469
-0.0531 (-7.59%)
NASDAQ · Last Trade: Oct 16th, 7:39 PM EDT
Detailed Quote
| Previous Close | 0.7000 |
|---|---|
| Open | 0.6400 |
| Bid | 0.5700 |
| Ask | 0.5880 |
| Day's Range | 0.5500 - 0.7199 |
| 52 Week Range | 0.5500 - 4.190 |
| Volume | 1,269,855 |
| Market Cap | 7.89M |
| PE Ratio (TTM) | -0.1382 |
| EPS (TTM) | -4.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,562,924 |
Chart
About SenesTech, Inc. - Common Stock (SNES)
Senestech Inc is a biotechnology company focused on the development of innovative solutions for pest control through its proprietary platform that employs the principles of biology and technology. The company's primary aim is to create environmentally friendly products that effectively manage pest populations while minimizing harmful impacts on non-target species and ecosystems. By utilizing a unique approach to target specific species, Senestech seeks to meet the growing demand for sustainable pest management solutions in various agricultural and residential markets. Read More
News & Press Releases
Wetour pauses ATM share sales, Peraso targets Physical AI connectivity, Dermata reports cosmetic study results and SenesTech announces record preliminary quarterly revenue.
Via AB Newswire · October 15, 2026
DALLAS, TX – October 15, 2026 – Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) announced major advancements in its next-generation G®CELLS Graphene Aluminum-Ion Battery technology, reporting a 48% increase in energy density, doubling of cycle life to 1,000 cycles and 94% energy efficiency during six-minute fast charging . The results could strengthen GMG's position in the growing markets for advanced battery technology, industrial energy storage and rapid-charging applications .
Via AB Newswire · October 15, 2026
E-commerce revenue surged 186% sequentially as management pivots to direct sales.
Via The Motley Fool · August 12, 2026
SenesTech (NASDAQ:SNES) Beats Q2 Revenue and EPS Estimates, Yet Shares Dip 6% After Hourschartmill.com
Via Chartmill · August 5, 2026
SenesTech Inc (NASDAQ:SNES) Q1 EPS Beat Drives After-Hours Stock Surge Despite Revenue Misschartmill.com
Via Chartmill · May 12, 2026
SenesTech SNES Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 14, 2026

SenesTech (SNES) Q4 2025 Earnings Call Transcript
Via The Motley Fool · March 12, 2026
Via Benzinga · November 11, 2025
SenesTech Q3 2025: Record revenue & strong product growth, but stock fell after a revenue miss. EPS beat estimates, showing improved cost control.
Via Chartmill · November 10, 2025
Via Benzinga · August 8, 2025
Via Benzinga · July 1, 2025
Via Benzinga · April 24, 2025
A discussion about the $4B rodent control market and the company’s game-changing product Evolve – a revolutionary form of rodent birth control.
Via Talk Markets · April 16, 2025
SenesTech, an under-the-radar biotech company with a focus on solving the global pest population problem through, humane fertility control measures, seems attractively valued.
Via Talk Markets · April 1, 2025
Via Benzinga · March 14, 2025
With no direct competition in the fertility control space and growing demand for non-lethal rodent management, could SNES be the next big winner? Find out in this deep-dive conversation with CEO Joel Fruendt.
Via Talk Markets · March 13, 2025
Via Benzinga · March 13, 2025
Via Benzinga · March 12, 2025